(Q41715512)

7 October 2017

1 reference

title

Long-acting beta(2)-agonists: how are they used in an optimal way? (English)

1 reference

7 October 2017

1

L Bjermer

1 reference

7 October 2017

L Larsson

2

1 reference

7 October 2017

1 November 1997

1 reference

7 October 2017

1 reference

7 October 2017

91

1 reference

7 October 2017

10

1 reference

7 October 2017

587-591

1 reference

Regular inhaled beta-agonist treatment in bronchial asthma.

7 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Are there any detrimental effects of the use of inhaled long-acting beta 2-agonists in the treatment of asthma?

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Regular inhaled salbutamol and airway responsiveness to allergen

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Rapid Onset of Tolerance to the Bronchoprotective Effect of Salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Lack of bronchial beta adrenoceptor resistance in asthmatics during long-term treatment with terbutaline

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Influence of budesonide on the response to inhaled terbutaline in children with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Reversal of human lymphocyte beta-adrenoceptor desensitization by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Terbutaline-induced desensitization of human lymphocyte beta 2-adrenoceptors. Accelerated restoration of beta-adrenoceptor responsiveness by prednisone and ketotifen

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Effects of inhaled fluticasone propionate and oral prednisolone on lymphocyte beta 2-adrenoceptor function in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Clinical pharmacology of long-acting beta-receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2897%2990004-4

7 January 2021

10.1016/S0954-6111(97)90004-4

Identifiers

DOI

1 reference

7 October 2017

1 reference

PubMed ID

9488891